MTOR and PTEN hamartoma tumor syndrome: The changes of PI3K/AKT/mTOR signaling pathway in PTEN mutant cancer patiens indicated that PI3K, AKT or mTOR are target for molecular therapy.417 PTEN hamartoma tumor syndrome (PHTS) is caused by pathogenic PTEN mutation in germline.